114 related articles for article (PubMed ID: 14698161)
1. Synthesis and biological characterisation of [3H]BBL454, a new CCK2 selective radiolabelled agonist displaying original pharmacological properties.
Bellier B; Dugave C; Etivant F; Genet R; Gigoux V; Garbay C
Bioorg Med Chem Lett; 2004 Jan; 14(2):369-72. PubMed ID: 14698161
[TBL] [Abstract][Full Text] [Related]
2. New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454.
Bellier B; Crété D; Million ME; Beslot F; Bado A; Garbay C; Daugé V
Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):404-13. PubMed ID: 15480577
[TBL] [Abstract][Full Text] [Related]
3. [3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors.
Durieux C; Corringer PJ; Bergeron F; Roques BP
Eur J Pharmacol; 1989 Sep; 168(2):269-70. PubMed ID: 2606153
[No Abstract] [Full Text] [Related]
4. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
[No Abstract] [Full Text] [Related]
5. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
6. Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.
Bellier B; Million ME; DaNascimento S; Meudal H; Kellou S; Maigret B; Garbay C
J Med Chem; 2000 Oct; 43(20):3614-23. PubMed ID: 11020275
[TBL] [Abstract][Full Text] [Related]
7. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
8. The cholecystokinin receptor agonist, CCK-8, induces adiponectin production in rat white adipose tissue.
Plaza A; Merino B; Del Olmo N; Ruiz-Gayo M
Br J Pharmacol; 2019 Aug; 176(15):2678-2690. PubMed ID: 31012948
[TBL] [Abstract][Full Text] [Related]
9. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
Fourmy D; Lopez P; Poirot S; Jimenez J; Dufresne M; Moroder L; Powers SP; Vaysse N
Eur J Biochem; 1989 Nov; 185(2):397-403. PubMed ID: 2583188
[TBL] [Abstract][Full Text] [Related]
10. Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs.
Shue YK; Tufano MD; Carrera GM; Kopecka H; Kuyper SL; Holladay MW; Lin CW; Witte DG; Miller TR; Stashko M
Bioorg Med Chem; 1993 Sep; 1(3):161-71. PubMed ID: 8081848
[TBL] [Abstract][Full Text] [Related]
11. How a single inversion of configuration leads to a reversal of the binding mode: proposal of a novel arrangement of CCK2 ligands in their receptor, and contribution to the development of peptidomimetic or non-peptide CCK2 ligands.
Bellier B; Garbay C
Eur J Med Chem; 2003; 38(7-8):671-86. PubMed ID: 12932898
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors.
Danho W; Makofske RC; Swistok J; Michalewsky J; Gabriel T; Marks N; Berg MJ; Baird L; Geiler V; Mackie G
Pept Res; 1991; 4(2):59-65. PubMed ID: 1815779
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.
Holladay MW; Bennett MJ; Tufano MD; Lin CW; Asin KE; Witte DG; Miller TR; Bianchi BR; Nikkel AL; Bednarz L
J Med Chem; 1992 Aug; 35(16):2919-28. PubMed ID: 1501220
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
[TBL] [Abstract][Full Text] [Related]
15. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
Dong M; Liu G; Pinon DI; Miller LJ
Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
[TBL] [Abstract][Full Text] [Related]
16. JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability.
Morton MF; Barrett TD; Freedman J; Li L; Rizzolio MC; Prendergast CE; Wu X; Moreno V; Pyati J; Figueroa K; Cagnon L; Lagaud G; Ver Donck L; Ghoos E; Allison B; Rabinowitz MH; Shankley NP
J Pharmacol Exp Ther; 2011 Jul; 338(1):328-36. PubMed ID: 21493750
[TBL] [Abstract][Full Text] [Related]
17. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
Bellier B; McCort-Tranchepain I; Ducos B; Danascimento S; Meudal H; Noble F; Garbay C; Roques BP
J Med Chem; 1997 Nov; 40(24):3947-56. PubMed ID: 9397175
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
20. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
Sugg EE; Kimery MJ; Ding JM; Kenakin DC; Miller LJ; Queen KL; Rimele TJ
J Med Chem; 1995 Jan; 38(1):207-11. PubMed ID: 7837233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
